In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...
Batoclimab receives Orphan Drug Designation in Japan, advancing treatment for active Thyroid Eye Disease (TED). Batoclimab, ...
Neuromodulation and robotics test new stroke recovery therapies. Experts assess research, benefits, and limitations to guide ...
Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...
The clinical trial results of India’s first CAR T-cell therapy, published in The Lancet, show that it worked for nearly 73 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results